Collectively, these findings underscore the importance of understanding the dysregulation of the adiponectin-PEPITEM pathway in different immune-mediated inflammatory diseases (IMIDs), such as RA and PsA. The observed differences in expression and downstream signaling through adiponectin receptors suggest potential targets for therapeutic intervention to restore the balance of this regulatory pathway to mitigate chronic inflammation and disease progression in these patients, paving the way for its clinical use as an alternative and/or combination therapy for early IMIDs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Mussarat Wahid
Samuel Kemble
Oladimeji Abudu
Arthritis & Rheumatology
University of Birmingham
University of Glasgow
University of Nottingham
Building similarity graph...
Analyzing shared references across papers
Loading...
Wahid et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69df2bece4eeef8a2a6b0e38 — DOI: https://doi.org/10.1002/art.70108